The acute and chronic administration of (±)-8-hydroxy-2-(Di-n- propylamino) tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: An in vivo electrophysiological study

Synapse

Volumn 59, Issue 6, 2006, Pages 359-367

  Nakamura, Kazuhiko ^a   Suzuki, Katsuaki ^a   McCreary, Andrew C ^b   Ashby Jr , Charles R ^c  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Solvay Pharmaceuticals Inc   (Netherlands)

^c ST JOHN'S UNIVERSITY   (United States)

Author keywords

8 OH DPAT; Dopamine neurons; In vivo electrophysiology; Substantia nigra pars compacta; Ventral tegmental area

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; APOMORPHINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DOPAMINERGIC NERVE CELL; ELECTROPHYSIOLOGY; IN VIVO STUDY; MALE; MESENCEPHALON; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; MALE; MESENCEPHALON; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGONISTS;

EID: 33645419546     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20254     Document Type: Article

References (72)

1. 1A binding site in the rat striatum. J Pharm Pharmacol 40:888-891.
2. Alhenius S, Hillegaart V, Wijkstrom A. 1990. Increased dopamine turnover in the ventral striatum by 8-OH-DPAT administration in the rat. J Pharm Pharmacol 42:285-288.
3. 1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons. Naunyn Schmied Arch Pharmacol 347:353-362.
4. Ashby CR, Jr., Wang RY. 1996. The pharmacological actions of the atypical antipsychotic drug clozapihe: a review. Synapse 24:349-394.
5. Ashby CR, Jr., Minabe Y, Strecker E, Dewey SL. 1995. The effect of the acute and chronic administration of fluoxetine on spontaneously active midbrain dopamine neurons: an in vivo electrophysiological study. Abstr Soc Neurosci, No. 153.2.
6. Assie MB, Koek W. 1996. Possible in vivo reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats. Br J Pharmacol 119:845-850.
7. Azmitia EC, Segal M. 1978. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 179:641-667.
8. Bonaventure P, Nepomuceno D, Heim L, Sutcliffe JG, Lovenberg T, Hedlund PB. 2004. Radioligand binding analysis of knockout mice reveals 5-hydroxytrptamine(7) receptor distribution and uncovers 8-hydroxy-2-(di-n- propylamino)tetralin interaction with alpha(2) adrenergic receptors. Neuroscience 124:901-911.
9. 2- adrenoceptors. J Auton Pharmacol 11:247-253.
10. Bunney BS, Grace AA. 1978. Acute and chronic haloperidol treatment: comparison of effects of nigral dopaminergic cell activity. Life Sci 23:1715-1728.
11. Bunney BS, Walter JR, Roth RH, Aghajanian GK. 1973. Dopaminergic neurons: effect of antipsychotic drugs and amphetamines on single cell activity. J Pharmacol Exp Ther 175:560-571.
12. 2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology 15:442-455.
13. 3H]-8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Neurochem Int 30:565-574.
14. 3H]5-hydroxytryptamine into rat cortical synaptosomes. Eur J Pharmacol 239:211-214.
15. Chiodo LA. 1988. Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology. Neurosci Biobehav Rev 12:49-91.
16. Chiodo LA, Bunney BS. 1983. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 dopamine neurons. J Neurosci 7:1607-1619.
17. Clark D, Chiodo LA. 1988. Electrophysiological and pharmacological characterization of identified nigrostriatal and mesoaccumbens dopamine neurons in the rat. Synapse 2:474-485.
18. 1A receptor agonist. I. Neurochemical and electrophysiological profile. Neuropsychopharmacology 28:2064-2076.
19. 1A receptors at the axon initial segment of prefrontal pyramidal neurons in schizophrenia. Am J Psychiatry 161:739-742.
20. 2/3 receptor agonist 7-OH-DPAT in the rat. Acta Physiol Scand 172:205-209.
21. Freeman AS, Bunney BS. 1987. Chronic neuroleptic effects on dopamine neuron activity: a model for predicting therapeutic efficacy and side effects. Psychopharmacol Ser 3:225-235.
22. Grace AA. 1992. The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of depression. J Neural Transm 36:91-131.
23. Grace AA, Bunney BS. 1984. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4:2877-2890.
24. Grace AA, Bunney BS. 1986. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording. J Pharmacol Exp Ther 238:1092-1100.
25. Grace AA, Bunney BS, Moore H, Todd CL. 1997. Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs. Trends Neurosci 20:31-37.
26. Gurevich EV, Joyce JN. 1997. Alterations in the cortical serotonergic system in schizophrenia: a postmortem study. Biol Psychiatry 42:529-545.
27. 7 receptor in rat brain. Br J Pharmacol 117:657-666.
28. Hamon M, Bourgoin S, Gozlan H, Hall MD, Goetz C, Artaud F, Horn AS. 1984. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propyl-amino)tetralin in the rat brain. Eur J Pharmacol 100:263-276.
29. 1A receptors: pharmacological, biochemical, functional, and regulatory properties. Ann N Y Acad Sci 600:114-131.
30. 7 receptors to induce hypothermia in rodents. Eur J Pharmacol 487:125-132.
31. Herve D, Pickel VM, Joh TH, Beaudet A. 1987. Serotonin axon terminals in ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res 435:71-83.
32. Jones-Humble SA, Durcan MJ, Lyerly D, Norton MS, Tang FLM, Russell AV, Watson MJ, Gengo PJ, Morgan PF, Wang CM, Cooper BR, Cox RF. 1996. Preclinical neurochemical and electrophysiological profile of 1192U90, a potential antipsychotic. Neuropsychopharmacology 15:217-229.
33. Kelland MD, Chiodo LA. 1996. Serotonergic modulation of midbrain dopamine systems. In: Ashby CR, Jr., editor. The Modulation of Dopaminergic Neurotransmission by other Neurotransmitters. New York: CRC Press, p 87-122
34. Kelland MD, Freeman AS, Chiodo LA. 1990. Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons. J Pharmacol Exp Ther 253:803-811.
35. 1A receptors. Eur J Neurosci 12:3265-3275.
36. 1A receptors and their modulation of the activity of serotonergic and dopaminergic neurones in rats. J Pharmacol Exp Ther 280:1241-1249.
37. 1A receptors in the dorsal raphe. Eur J Pharmacol 149:9-15.
38. 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n- dipropylamino)tetralin. Br J Pharmacol 89:277-286.
39. 1A, antagonist. Brain Res 820:55-62.
40. 1A agonist: efficacy in antipsychotic models with reduced propensity for EPS symptoms. Abstr Soc Neurosci, No. 349.1.
41. 1 recognition site. Eur J Pharmacol 90:151-153.
42. 1A receptors. J Pharmacol Exp Ther 295:853-861.
43. Millan MJ, Colpaert FC. 1991. Alpha2 receptors mediate the antinocicpetive action of 8-OH-DPAT in the hot-plate test in mice. Brain Res 539:342-346.
44. 1A agonist properties. I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol. J Pharmacol Exp Ther 286:1341-1355.
45. 1A agonist properties. II. Functional profile in comparison with clozapine and haloperidol. J Pharmacol Exp Ther 286:1356-1373.
46. B receptor antagonist L-365, 260, reverses the effects of chronic haloperidol and clozapine on midbrain dopamine neurons in the rat. Brain Res 549:151-154.
47. Muscat R, Montgomery AM, Wilner P 1989. Blockade of 8-OH-DPAT-induced feeding by dopamine antagonists. Psychopharmacology 99:402-408.
48. 7 receptors in rat brain by immunocytochemistry, in situ hybridization and agonist stimulated c-Fos expression. J Chem Neuroanat 21:63-73.
49. 1A receptors: A [35S]GTPγS binding study. Eur J Pharmacol 355:245-256.
50. 1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia. Int J Neuropsychopharmacol 11:1-16.
51. 2 receptors differentially modulate dopamine-mediated auto-inhibition of A9 and A10 midbrain area of the rat. Neuropharmacology 46:504-510.
52. Overton PG, Clark D. 1997. Burst firing in midbrain dopaminergic neurons. Brain Res Rev 25:312-334.
53. Overton PG, Tong ZY, Clark D. 1996. A pharmacological analysis of the burst events induced in midbrain dopaminergic neurons by electrical stimulation of the medial prefrontal cortex in the rat. J Neural Transm Gen Sect 103:523-540.
54. Paxinos G, Watson C. 1986. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press.
55. Phillipson OT. 1979. Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: a horseradish peroxidase study in the rat. J Comp Neurol 187:117-143.
56. Prisco S, Pagannone S, Esposito E. 1994. Serotonin-dopamine interaction on the rat ventral tegmental area: an electrophysiological study in vivo. J Pharmacol Exp Ther 271:83-90.
57. Protais P, Chagraoui A, Arbaoui J, Mocaer E. 1994. Dopamine receptor antagonist properties of S14506, 8-OH-DPAT, raclopride and clozapine in rodents. Eur J Pharmacol 271:167-177.
58. 2 receptor. Neuroreport 25:493-495.
59. 7 receptor-mediated effects on 5-HT efflux in guinea-pig dorsal raphe nucleus. Neuropharmacology 46:935-941.
60. 1A receptor activation. Eur J Pharmacol 338:R3-R5.
61. Ruat M, Traiffort E, Leurs R, Tardivel-Lacombe J, Diaz J, Arrang JM, Schwartz JC. 1993. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl Acad Sci USA 90:8547-8551.
62. Shen Y, Monsma FJ, Jr., Metcalf MA, Jose PA, Hamblin MW, Sibley DR. 1993. Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J Biol Chem 268:18200-18204.
63. 1 receptors. Eur J Pharmacol 157:173-181.
64. Skarsfeldt T. 1988. Differential effects after repeated administration with haloperidol, clozapine, thioridazine and tefludazine on SNC and VTA dopaminergic neurons. Life Sci 42:1037-1044.
65. Skarsfeldt T. 1992. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurons in rats: acute and repeated treatments. Synapse 10:25-33.
66. Slater P, Doyle CA, Deakin JFW. 1998. Abnormal persistence of cerebellar serotonin1A receptors in schizophrenia suggests failure to regress in neonates. J Neural Transm 105:305-315.
67. Smith CF, Cutts S. 1990. dopamine agonist activity of 8-OH-DPAT. Arch Int Pharmacodyn Ther 306:106-113.
68. 2 receptor antagonist MDL 100907 as a putative atypical anti-psychotic: behavioral, electrophysiological and neurochemical studies. J Pharmacol Exp Ther 266:684-691.
69. Tsuo AP, Kosaka A, Bach C, Zuppan P, Yee C, Tom L, Alvarez R, Ramsey S, Bonhaus DW, Stefanich E. 1994. Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylate cyclase. J Neurochem 63:456-464.
70. Van Wijngaarden I, Tulp MThM, Soudijn W. 1990. The concept of selectivity in 5-HT receptor research. Eur J Pharmacol Mol Pharmacol Sect 188:301-312.
71. White FJ, Wang RY. 1983. Differential effects of classical and a typical antipsychotic drugs on A9 and A10 dopamine neurons. Science 225:1054-1057.
72. 1A receptor binding in amygdala of schizophrenia. Biol Psychiatry 55:439-444.